Search research articles
Contact Us
Filters
Showing results (101-110 of 106) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 106 results.
Journal of Parkinson'S Disease
|
January 23, 2026
Analysis of α-synuclein seed amplification assay in carriers of <i>GBA1</i> and <i>LRRK2</i> pathogenic variants
Kyle B Fraser, Anat Mirelman, Omar S Mabrouk, et al.
NPJ Parkinson'S Disease
|
January 3, 2025
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients
Amgad Droby, Avital Yoffe-Vasiliev, Daniel Atias, et al.
Virology
|
September 8, 2025
Genomic analysis and preclinical evaluation of two hydrogel-formulated novel virulent phages isolated against a carbapenem-resistant Acinetobacter baumannii
Ann A Elshamy, Sandra K Kamal, Mariam T Mahmoud, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 22, 2023
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease
Danna Jennings, Sarah Huntwork-Rodriguez, Maurits F J M Vissers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 16, 2026
Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy
Louise-Kristine Nielsen, Joshua L I Frost, David P Vaughan, et al.
Nature Medicine
|
March 25, 2026
LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial
Omar S Mabrouk, Ben Tichler, H Moore Arnold, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 106) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 106 results.
Journal of Parkinson'S Disease
|
January 23, 2026
Analysis of α-synuclein seed amplification assay in carriers of <i>GBA1</i> and <i>LRRK2</i> pathogenic variants
Kyle B Fraser, Anat Mirelman, Omar S Mabrouk, et al.
NPJ Parkinson'S Disease
|
January 3, 2025
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients
Amgad Droby, Avital Yoffe-Vasiliev, Daniel Atias, et al.
Virology
|
September 8, 2025
Genomic analysis and preclinical evaluation of two hydrogel-formulated novel virulent phages isolated against a carbapenem-resistant Acinetobacter baumannii
Ann A Elshamy, Sandra K Kamal, Mariam T Mahmoud, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 22, 2023
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease
Danna Jennings, Sarah Huntwork-Rodriguez, Maurits F J M Vissers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 16, 2026
Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy
Louise-Kristine Nielsen, Joshua L I Frost, David P Vaughan, et al.
Nature Medicine
|
March 25, 2026
LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial
Omar S Mabrouk, Ben Tichler, H Moore Arnold, et al.
Page
of 11